Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with KROS: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
KROS
Keros Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
KROS
Keros Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,421.27
▲
+0.84%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
KROS
Keros Therapeutics, Inc.
Change
10.90
▲
+0.68%
Regular session
Nov 4 '26
Mkt cap
$214.7M
Revenue
$367,000
Q1 FY26
Revenue
$244M
FY25
vs
Compare
Regular session
Nov 4 '26
LLY
ELI Lilly & Co
vs
KROS
Keros Therapeutics, Inc.
1,421.27
▲
+0.84%
Price
10.90
▲
+0.68%
$1.3T
Mkt cap
$214.7M
Q3 FY26
$24.4B
Revenue
$367,000
Q1 FY26
FY25
$65.2B
Revenue
$244M
FY25
Change
Change
LLY
1,421.27
▲
+0.84%
vs
KROS
10.90
▲
+0.68%
Regular session
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
KROS: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
KROS, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only KROS
4
TAK
Takeda Pharmaceutical
customer
—
The General Hospital
unlisted
supplier
—
Hansoh (Shanghai) Healthtech
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Takeda Pharmaceuticals U.S.A
unlisted
customer